Letter: Lithium in Parkinson's disease.
D002254:Carbonates / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000009:adverse effects / Q000627:therapeutic use; D004336:Drug Antagonism; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D008094:Lithium / Q000008:administration & dosage / Q000627:therapeutic use*; D009069:Movement Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*
D002254:Carbonates; D004295:Dihydroxyphenylalanine; D008094:Lithium